UFP Technologies EPS UFPT
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $9.28
- Latest quarter, Q2 FY26
- $2.68
- +21% on a year earlier
- Fiscal year 2025
- $8.78
- +16% on the year before
UFP Technologies' earnings per share was $9.28 over the twelve months to Jun 30, 2026, up 8% on a year earlier.
In its latest quarter, Q2 FY26, it was $2.68, up 21% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 38% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $8.78 | +16% |
| FY2024 | $7.59 | +30% |
| FY2023 | $5.84 | +7% |
| FY2022 | $5.46 | +161% |
| FY2021 | $2.09 | +17% |
| FY2020 | $1.78 | −32% |
| FY2019 | $2.63 | +36% |
| FY2018 | $1.93 | +53% |
| FY2017 | $1.26 | +15% |
| FY2016 | $1.10 | +4% |
| FY2015 | $1.06 | +0% |
| FY2014 | $1.06 | −33% |
| FY2013 | $1.59 | +3% |
| FY2012 | $1.54 | +3% |
| FY2011 | $1.49 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $2.68 | +21% | $9.28 | |
| Q1 FY26 | $2.24 | +1% | $8.81 | |
| Q4 FY25 | $2.25 | +8% | $8.78 | |
| Q3 FY25 | $2.11 | +0% | $8.62 | |
| Q2 FY25 | $2.21 | +26% | $8.62 | |
| Q1 FY25 | $2.21 | +35% | $8.16 | |
| Q4 FY24 | $2.09 | +39% | $7.59 | |
| Q3 FY24 | $2.11 | +39% | $7.00 | |
| Q2 FY24 | $1.75 | +13% | $6.41 | |
| Q1 FY24 | $1.64 | +29% | $6.21 | |
| Q4 FY23 | $1.50 | +38% | $5.84 | |
| Q3 FY23 | $1.52 | −41% | $5.43 |
Against its peers
Companies in Medical - Instruments & Supplies nearest UFP Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| UFPTUFP Technologies | $9.28 | +8% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| ATRCAtriCure | $0.21 | |
| WRBYWarby Parker | $0.07 | |
| EYENational Vision | $0.61 | |
| NVSTEnvista | $0.58 | +81% a year |
| CDRECadre | $0.81 | −14% a year |
| ICUIICU Medical | $1.18 | |
| BVSBioventus | $0.77 | |
| BMIBadger Meter | $4.28 | −8% a year |
| Peer median | $0.79 |
Where UFP Technologies ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on UFP Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.